Bend Bioscience Industry Insights

  1. Early Development Considerations For Late-Stage NCE Success – Part One 12/8/2023

    Navigating NCE development can be daunting. Learn about the importance of assessing and mitigating risk at every stage of development and ensure that your NCE has the maximum potential for success.

  2. What Information Does A CDMO Need To Deliver A Good Proposal? 12/6/2023

    Learn about the importance of sharing as much information as possible with your CDMO and how asking the right set of questions will ensure that services are fairly priced and timelines are accurate.

  3. The Role Of The Technical Transfer Executive Sponsor 10/30/2023

    Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.

  4. Key Pillar Of A Successful CDMO: Exceptional Regulatory Compliance 10/18/2023

    Ensuring regulatory compliance is paramount for a CDMO to meet manufacturing standards, warrant patient safety, and maintain its reputation.

  5. Over The Hurdles: Taking Psychedelics From Schedule I To Pharmacy 10/12/2023

    Learn how a partner with experience in handling scheduled substances and navigating FDA and DEA regulation can help you advance toward clinical research and drug development with ease.

  6. Tapping Into The Unexplored Through 505(b)(2) Pathway 10/9/2023

    Leveraging the the 505(b)(2) regulatory pathway can enable an accelerated approval timeline and help advance your drug product to market. Review the three statutes that govern the approval pathways.

  7. The Right Polymers For Your Modified Release Multiparticulate Capsule 10/9/2023

    Pharma companies aiming to tech transfer or scale-up modified release formulations often encounter hurdles when the formulation is not robust. Review how to select the right polymers and ensure you have a robust formulation strategy.

  8. Navigating The Pharma Supply Chain: Balancing Risk And Resilience 10/9/2023

    Leveraging an experienced partner with a robust supply strategy can help manage the strain of a supply chain in flux and mitigate risk during the development and manufacturing processes.

  9. Choosing The Right Clinical Trial Packaging Partner: 5 Cs To Consider 10/9/2023

    Today’s clinical studies demand flexible clinical trial services (CTS). Knowing what to look for when evaluating a CDMO can help avoid delays and ensure your product advances to market on schedule.

  10. Don't Skip Preformulation: Your Blueprint For Drug Development Success 9/22/2023

    Investing in the right preformulation studies and gathering evidence to inform decisions is critical to identify product dead-ends and failure modes without the pain of hindsight.